Eterna Therapeutics Inc. announced that Gregory Fiore, M.D., President and CEO of Exacis, and member of Eterna's Board of Directors, will chair a newly added committee on Eterna's Board focusing on business development, and Eterna's team will be joined by Exacis' Chief Business Officer, Dimitrios Goundis, Ph.D., who will advise the Company on business development matters. Dr. Goundis is a highly experienced scientist and biotech executive, formerly the Head of Research and Development at The Medicines Company (now Novartis) as well as former CEO of the clinical stage cancer vaccine company, Maxivax S.A. Eterna plans to continue working with the esteemed physicians and scientists who serve on Exacis' Scientific Advisory Board and who will advise Eterna on the development of products based on Eterna's suite of mRNA cell engineering technologies.